1. Anabolic Steroid Use for Weight and Strength Gain in Critically Ill Patients: A Case Series and Review of the Literature
- Author
-
Matthew Anstey, Luke E Torre, Emma Osnain, Shilpa Desai, Jason Seet, and Bradley Wibrow
- Subjects
medicine.medical_specialty ,Weakness ,Critical Illness Myopathy ,Anabolism ,business.industry ,medicine.medical_treatment ,Sedation ,lcsh:Medical emergencies. Critical care. Intensive care. First aid ,Case Report ,lcsh:RC86-88.9 ,Critical Care and Intensive Care Medicine ,Intensive care unit ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Weight loss ,law ,medicine ,030212 general & internal medicine ,medicine.symptom ,business ,Intensive care medicine ,Complication ,030217 neurology & neurosurgery ,Anabolic steroid - Abstract
Background. An important long-term complication of critical illness is significant weakness and its resulting functional impairment. Recent advances have aimed to prevent critical illness weakness via early mobilisation of patients, minimising sedation, and optimising nutrition. One other potential treatment may be to provide anabolic support in the recovery phase, especially as patients have decreased levels of anabolic hormones. Case Presentation. We describe a case series of 4 patients who had either (1) profound critical illness myopathy and (2) profound weight loss. All patients were already receiving appropriate nutritional support and physiotherapy. All patients had functional improvements in their muscle strength. Conclusions. For patients in the recovery phase of critical illness, we provide examples of when anabolic steroid supplementation may assist the treating clinicians in rehabilitating their patients who are still in the Intensive Care Unit. We discuss patient selection and the current supporting literature for anabolic supplementation in critically ill patients.
- Published
- 2018
- Full Text
- View/download PDF